Cutaneous Manifestations Associated with COVID-19 Infection. A Review of the Literature.
Keywords:
SARS-CoV-2, COVID-19, Dermatology, Cutaneous manifestationsAbstract
The SARS-CoV-2 infection has spread rapidly until it has been classified as a pandemic. COVID-19 disease can affect different systems, the respiratory system being the most compromised, however it can injure other organs, including the skin; dermatological semiology is heterogeneous and complex, and it has been related to the immune response to the nucleotides of the new betacoronavirus or eruptions secondary to sequelae of the infection. For this review of the narrative type literature, an exhaustive search of scientific literature was carried out in order to describe the most common skin manifestations in children and adults, also with the objective of characterizing them, where it was found that manifestations have been described in adults skin types: vesicular rashes, urticarial eruptions, maculopapular rashes and livedoid/necrotic lesions, and lesions such as erythematous maculopapular rash, chilblains, and erythema multiforme have been described in children. The most common symptom manifested is mild pruritus, and mucosal involvement is rare. Knowledge of the cutaneous manifestations of COVID-19 is important since the foregoing may allow an early diagnosis together with an impact on morbidity and mortality rates.
Downloads
References
Li Q, Guan X, Wu P, Wang X, Zhou L, Trong Y et al. Early transmission dynamics in Wuhan, China, of novel coronavirus– infected pneumonia. N Engl J Med. 2020. DOI: 10.1056/ NEJMoa2001316.
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020. DOI: 10.1056/NEJMoa2001017.
Elizalde GJJ. SARS-CoV-2 y COVID-19. Una revisión de la pandemia. Med Crit. 2020; 34(1):53-67. DOI:10.35366/93281.
Drenovska K, Schmidt E, Vassileva S. Covid-19 pandemic and the skin. International journal of dermatology, 2020. DOI:10.1111/ijd.15189
Ricaurte A, Hernández V, Garnica M. Características clínicas de las manifestaciones extrapulmonares de la infección COVID-19. Salutem Scientia Spiritus. 2020; 6(1):116-123.
Ministerio de Salud y Protección Social Colombiano. El Coronavirus en Colombia. 2020. Disponible en:https://coronaviruscolombia.gov.co/Covid19/index.html
Maroto M, Piédrola G. Coronaviruses. ANALES RANM. Royal Spanish Academy of Medicine. 2019; 136(03):262-265. DOI:10.32440/ar.2019.136.03.rev01
Lai MM, Cavanagh D. The molecular biology of coronaviruses. Adv Virus Res. 1997; 48:1-100. DOI: 10.1016/S0065-3527(08)60286-9.
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395(10224):565-574. DOI: 10.1016/S0140-6736(20)30251-8.
Li F. Structure, Function, and Evolution of Coronavirus Spike Proteins. Annu Rev Virol. 2016; 3(1):237-261. DOI: 10.1146/annurev-virology-110615-042301.
Chan JF-W, Kok K-H, Zhu Z, Chu H, To KK-W, Yuan S et al. Genomic 387 characterization of the 2019 novel human-pathogenic coronavirus isolated 388 from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes 389 Infect. 2020; 9:221-36. DOI: 10.1080/22221751.2020.1719902.
Andina D, Bellon-Fortina A, Bodemer C, Bonifazi E, Chiriac A, Colmenero I et al. Skin manifestations of COVID-19 in children: Part 2. Clinical and Experimental Dermatology, 2-3.2020. DOI: 10.1111/ced.14482
Wu Z, McGoogan JM. Characteristics of and Important Lessons From the 380 Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a 381 Report of 72.314 Cases From the Chinese Center for Disease Control and 19.382 Prevention. JAMA 2020. DOI: 10.1001/jama.2020.2648.
Ministerio de Sanidad. Centro de Coordinación de Alertas y Emergencias Sanitarias. Información científica - técnica. Enfermedad por coronavirus, COVID-19. 2021. Disponible en: https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/ITCoronavirus.pdf
Rodriguez A. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Medicine and Infectious Disease.2020;30(40). DOI: 10.1016/j.tmaid.2020.101623
Abduljalil J, Abduljalil B. Epidemiology, genome, and clinical features of the pandemic SARS-CoV-2: a recent view. New Microbes and New Infections. 2020; 35:100672. DOI: 10.1016/j.nmni.2020.100672
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J et al. Clinical characteristics of coronavirus disease 2019 in China.N Engl J Med. 2020; 382:1708-20. DOI:10.1056/NEJMoa2002032
Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol. 2020; 34(5):e212-e213. DOI: 10.1111/jdv.16387.
Galván C, Català A, Carretero G, Rodríguez-Jiménez P, Fernández-Nieto D, Rodríguez-Villa Lario A et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020; 183(1):71-77. DOI: 10.1111/bjd.19163.
Hedou M, Carsuzaa F, Chary E, Hainaut E, Cazenave-Roblot F, Masson Regnault M. Comment on ‘Cutaneous manifestations in COVID-19: a first perspective’ by Recalcati S. J Eur Acad Dermatol Venereol. 2020; 34(7):e299-e300. DOI: 10.1111/jdv.16519.
Cano L, Hernández C, Vega M. Primary Skin Manifestations by the Severe Acute Respiratory Syndrome Coronavirus 2. Review of Literature. Dermatología CMQ. 2020; 18(2):129-135
Marzano AV, Genovese G, Moltrasio C, et al. The clinical spectrum of COVID-19-associated cutaneous manifestations: An Italian multicenter study of 200 adult patients. J Am Acad Dermatol. 2021;84(5):1356-1363. doi:10.1016/j.jaad.2021.01.023
Carrascosa J.Morillas V.Bielsa I.Munera-Campos M.Manifestaciones cutáneas en el contexto de la infección por SARS-CoV-2 (COVID-19). Actas Dermo-Sifiliográficas.2020;111(9),734-742.https://doi.org/10.1016/j.ad.2020.08.002
En la piel también se reflejan síntomas de COVID-19. Revista Pesquisa Javeriana. 2020. Disponible en: https://www.javeriana.edu.co/pesquisa/en-la-piel-tambien-se-reflejan-sintomas-de-covid-19/
Recalcati S, Barbagallo T, Frasin LA, Prestinari F, Cogliardi A, Provero MC. Et al. Acral cutaneous lesions in the time of COVID-19. J Eur Acad Dermatol Venereol. 2020; 34(8):e346-e347. DOI: 10.1111/jdv.16533.
Romaní J, Baselga E, Mitjà O, Riera-Martí N, Garbayo P, Vicente A et al. Chilblain and Acral Purpuric Lesions in Spain during Covid Confinement: Retrospective Analysis of 12 Cases.Actas Dermo-Sifiliograficas. 2020; 111(5):426-429. DOI: 10.1016/j.ad.2020.04.002
Marzano A, Genovesse G, Fabbrocini G, Rongioletti F, Berti E, Calzavara-Pinton P et al.Varicella-like exanthem as a specific COVID-19-associated skin manifestation: Multicenter case series of 22 patients. Journal of the American Academy of Dermatology. 2020; 83(1):280-285. DOI: 10.1016/j.jaad.2020.04.044
Fernández-Nieto D, Ortega-Quijano G, Segurado-Miravalles C, Pindado-Ortega M, Prieto-Barrios et al. Comment on: Cutaneous manifestations in COVID-19: a first perspective. Safety concerns of clinical images and skin biopsies. J Eur Acad Dermatol Venereol. 2020; 34(6):e252-e254. DOI: 10.1111/jdv.16470.
Ehsani AH, Nasimi M, Bigdelo Z, Pityriasis rosea as a cutaneous manifestation of COVID-19 infection.J Eur Acad Dermatol Venereol. 2020; 34(9):e436-e437. DOI: 10.1111/jdv.16579.
Estébanez A, Pérez L, Silva E, Guillen-Climent S, García-Vázquez A, Ramón MD. Cutaneous manifestations in COVID-19: a new contribution. J Eur Acad Dermatol Venereol. 2020; 34(6):e250-e251. DOI: 10.1111/jdv.16474.
Paolino G, Canti V, Mercuri SR, Rovere-Querini P, Candiani M, Pasi F. Diffuse cutaneous manifestation in a new mother with COVID-19 (SARS-Cov-2). Int J Dermatol. 2020; 59(7):874-875. DOI: 10.1111/ijd.14919
Avellana R, Estela LM, Avellana V, Estela C, Moreno MA, Avellana JA. Cutaneous manifestation of COVID-19 in images: a case report. J Eur Acad Dermatol Venereol. 2020; 34(7):e307-e309. DOI: 10.1111/jdv.16531.
Mahé A, Birckel E, Krieger S, Merklen C, Bottlaender L. A distinctive skin rash associated with coronavirus disease 2019? J Eur Acad Dermatol Venereol. 2020; 34(6):e246-e247. DOI: 10.1111/jdv.16471.
Gianotti R, Veraldi S, Recalcati S, Cusini M, Ghislanzoni M, Boggio F, Fox LP. Cutaneous Clinico-Pathological Findings in three COVID-19-Positive Patients Observed in the Metropolitan Area of Milan, Italy. Acta Derm Venereol. 2020; 100(8):adv00124. DOI: 10.2340/00015555-3490.
Jin Y, Yang H, Ji W, Wu W, Chen S, Zhang W, Duan G. Virology, Epidemiology, Pathogenesis, and Control of COVID-19. Viruses. 2020; 12(4):372. DOI: 10.3390/v12040372.
Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19. N Engl J Med. 2020; 382(17):1653-1659. DOI: 10.1056/NEJMsr2005760.
Magro C, Mulvey JJ, Berlin D, Nuovo G, Salvatore S. Harp J, Baxter-Stoltzfus A, Laurence J. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases. Transl Res. 2020; 220:1-13. DOI: 10.1016/j.trsl.2020.04.007.
Torrelo A, Andina D, Santonja C et al. Erythema multiforme-like lesions in children and COVID-19. Pediatr Dermatol. 2020;37(3):442-446. DOI:10.1111/pde.14246
Gisondi P, PIaserico S, Bordin C, Alaibac M, Girolomoni G, Naldi L. Cutaneous manifestations of SARS-CoV-2 infection: a clinical update. J Eur Acad Dermatol Venereol 2020. DOI: 10.1111/jdv.16774
De Giorgi V, Recalcati S, Jia Z, Chong W, Ding R, Deng Y et al. Cutaneous manifestations related to coronavirus disease 2019 (COVID-19): A prospective study from China and Italy. J Am Acad Dermatol. 2020; 83(2):674-675. DOI: 10.1016/j.jaad.2020.05.073.
Fernandez-Nieto D, Ortega-Quijano D, Cuhe J, Burgos-Blasco P, Perosanz L et al. Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital. Clin Exp Dermatol. 2020; 45(7):872-875. DOI: 10.1111/ced.14277.
Tang K, Wang Y, Zhang H, Zheng Q, Fang R, Sun Q. Cutaneous manifestations of the Coronavirus Disease 2019 (COVID-19): A brief review. Dermatol Ther. 2020; 33(4):e13528. DOI: 10.1111/dth.13528.
Dong Y, Mo X, Hu Y, Xin Q, Jiang F, Jiang Z et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020; 145: e20200702.DOI:10.1542/peds.2020-0702
Jones VG, Mills M, Suarez D et al. COVID-19 and Kawasaki Disease: novel virus and novel case. Hosp Pediatr. 2020. DOI: 101542/hpeds.2020-0123.
Sociedad Argentina de Pediatría. Síndrome inflamatorio multisistémico post-COVID19 en pediatría.2020.Disponible en: https://www.sap.org.ar/uploads/archivos/general/files_sindrome-inflamatorio-multisistemico-post-covid-_1595978132.pdf
Cappel JA. Wetter DA. Clinical characteristics, etiologic associations, laboratory findings, treatment, and proposal of diagnostic criteria of pernio (chilblains) in a series of 104 patients at Mayo Clinic, 2000 to 2011. Mayo Clin Proc. 2014 Feb;89(2):207-15. doi: 10.1016/j.mayocp.2013.09.020.
Andina D, Belloni-Fortina A, Bodemer C, Bonifazi E, Chiriac A, Colmenero I et al. A ESPD Group for the Skin Manifestations of COVID-19. Skin manifestations of COVID-19 in children: Part 1. Clin Exp Dermatol. 2020. DOI: 10.1111/ced.14481.
Andina D, Noguera-Morel L, Bascuas-Arribas M, Gaitero-Tristán J, Alonso-Cadenas J, Escalada-Pellitero S et al. Chilblains in children in the setting of COVID-19 pandemic. Pediatr Dermatol. 2020; 37(3):406-411. DOI: 10.1111/pde.14215.
Zhang Y, Cao W, Xiaxo M, Yang Y, Zhao J, Zhou X et al.Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia. 2020; 41(0):E006. DOI: 10.3760/cma.j.issn.0253-2727.2020.0006.
Li T, Lu H, Zhang W. Clinical observation and management of COVID-19 patients. Emerg Microbes Infect. 2020; 9(1):687-690. DOI: 10.1080/22221751.2020.1741327.
Rahimi H, Tehranchinia Z. A comprehensive review of cutaneous manifestations associated with COVID-19.Biomed Res Int. 2020; 2020:1236520. DOI: 10.1155/2020/1236520
Boostani R, Talab F, Meibodi N, Zemorshidi F. COVID-19 associated with sensorimotor polyradiculoneuropathy and skin lesions: A case report. Journal of Neuroimmunology. 2021; 350:577434.DOI: 10.1016/j.jneuroim.2020.577434
Daneshgaran G, Dubin D, Gould D. Cutaneous Manifestations of COVID-19: An Evidence-Based Review. American Journal of Clinical Dermatology. 2020, 21(5):627-639. DOI: 10.1007/s40257-020-00558-4
Potekaev N, Zhukova O, Protsenko D, Demina O, Khlystova E, Bogin V. Clinical characteristics of dermatologic manifestations of COVID-19 infection: case series of 15 patients, review of literature, and proposed etiological classification. International Journal of Dermatology. 2020; 59(8):1000-1009. DOI: 10.1111/ijd.15030
Echeverria RR, Caceres OJ, Quiñones-Laveriano D, Sueyoshi JH. Manifestaciones cutáneas en un paciente con COVID-19. Reporte de un caso en la selva peruana. Rev Fac Med. 2021; 69(1). DOI: 10.15446/revfacmed.v69n1.88723.
Zhao Q, Fang X, Pang Z, Zhang B, Liu H, Zhang F. COVID-19 and cutaneous manifestations: a systematic review. J Eur Acad Dermatol Venereol. 2020; 34(11):2505-10. DOI: 10.1111/jdv.16778
Olisova O.Anpilogova E. Shnakhova L.Cutaneous manifestations in COVID-19: A skin rash in a child. Dermatologic Therapy. 2020; 1-2. DOI: 10.1111/dth.13712
Janah H, Zinebi A, Elbenaye J. Atypical erythema multiforme palmar plaques lesions due to Sars-Cov-2. Journal of the European Academy of Dermatology and Venereology. 2020; 34(8):1-5. DOI: 10.1111/jdv.16623
Torrelo A, Andina D, Santoja C, Noguera L, Bascuas M, Tristán J et al. Erythema multiforme-like lesions in children and COVID-19. Pediatric Dermatology. 2020; 37(3):442-446. DOI: 10.1111/pde.14246
García-Gil M, García M, Monte J, Prieto L, Ara-Martín M. Acral purpuric lesions (erythema multiforme type) associated with thrombotic vasculopathy in a child during the COVID-19 pandemic. Journal of the European Academy of Dermatology and Venereology. 2020; 34(9):1-8. DOI: 10.1111/jdv.16644
Oliva S, Martín L, Carozo B, Galindo R, Lozano G, Toro I et al. Skin Manifestations During the COVID-19 Pandemic in the Pediatric Emergency Department. Pediatrics International. 2020; 1-11. DOI: 10.1111/ped.14568
Morey-Olivé M, Espiau M, Mercadal-Hally M, Lera-Carballo E, García-Patos V. Manifestaciones cutáneas en contexto del brote actual de enfermedad por coronavirus 2019. Anales de Pediatría.2020. 92(6), 374-375. https://doi.org/10.1016/j.anpedi.2020.04.013
Maqueda G. Dermatological manifestations of COVID-19 infection in paediatrics. Rev Clín Med Fam. 2020; 13(2):166-70.
Labé P, Ly A, Sin C, Nasser M, Chapelon-Fromont E, Ben Saïd P, Mahé E. Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children. Journal of the European Academy of Dermatology and Venereology. 2020; 34(10):1-12. DOI: 10.1111/jdv.16666
Granados L. Manifestaciones cutáneas en pacientes pediátricos infectados por el coronavirus SARS-CoV-2. Rev Cubana de Pediatría. Revista Cubana de Pediatría. 2020; 92:1-13.
Gutierrez L, Aldama A, Rivelli V, Ximenes A, Nunes D. Lesiones en piel en pediatría en periodos de covid-19. reporte de un caso. Pediatría (Asunción). 2020; 47(2):100-102. DOI: 10.31698/ped.47022020011
Klimach A, Evans J, Stevens J, Creasey N. Rash as a presenting complaint in a child with COVID-19. Pediatric Dermatology. 2020; 37(5):966-967. DOI: 10.1111/pde.14257
Promenzio L, Arcangeli F, Cortis E, Sama E, Longhini F. Erythema Pernio-like in four Adolescents in the era of the Coronavirus-2 Infection. Rev Recent Clin Trials. 2020. DOI: 10.2174/1574887115666201016153031.
Mazzotta F, Troccoli T. Acute acro-ischemia in the child at the time of COVID-19. Eur J Pediat Dermatol. 2020; 30(2):71-74.DOI: 10.26326/2281-9649.30.orci
Singh H, Kaur H, Singh K, Sen CK. Cutaneous Manifestations of COVID-19: A Systematic Review. Adv Wound Care (New Rochelle). 2021; 10(2):51-80. DOI:10.1089/wound.2020.1309
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Salutem Scientia Spiritus
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
La Revista Salutem Scientia Spiritus usa la licencia Creative Commons de Atribución – No comercial – Sin derivar: Los textos de la revista son posibles de ser descargados en versión PDF siempre que sea reconocida la autoría y el texto no tenga modificaciones de ningún tipo.
